MEG3 and neoplasm: Moreover, a multidrug resistance-reversing agent, Schisandrin A, has been reported to repress the tumor growth in choriocarcinoma cells by upregulating MEG3 expression and downregulating PI3K/AKT/NF-κB signal cascade [248].